Efficacy of transcutaneous electrical acupoint stimulation in prevention and treatment of chronic pain after breast cancer surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2022000022

Enrollment

Unknown

Registered

2022-06-20

Start date

2022-07-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain after breast cancer surgery

Interventions

Treatment Group:TEAS

Control Group:Placebo-TEAS

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients between the ages of 18 and 70 requiring elective breast cancer surgery under general anesthesia ; ASA grades I-II.

Exclusion criteria

Exclusion criteria: ASA grade =III;Diabetes mellitus;patients after cardiac pacemaker implantation;Previous acupuncture treatment history;History of chronic pain;Associated with neurological diseases;Taking antipsychotic medications;Long-term use of analgesics or alcohol abuse;BMI>30kg/m2

Design outcomes

Primary

Measure	Time frame
Pain scores ;	—

Secondary

Measure	Time frame
HAD scores;The pain scores ;Nausea and vomiting scores;	—

Countries

China

Contacts

Public ContactXi-Chen Dong

gamhdongxc@aliyun.com13810248772

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026